Skip to content

D&A at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2B+13.1%
Medtronic logo
MedtronicMDT
$716M-14.8%
Boston Scientific logo
Boston ScientificBSX
$351M+8.0%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's D&A?
Penumbra (PEN) reported D&A of $4.57M in Q1 2026.
How has Penumbra's D&A changed year-over-year?
Penumbra's D&A decreased by 8.8% year-over-year, from $5.02M to $4.57M.
What is the long-term trend for Penumbra's D&A?
Over 4 years (2021 to 2025), Penumbra's D&A has grown at a 1.6% compound annual growth rate (CAGR), from $16.41M to $17.47M.
What does D&A mean?
The non-cash expense representing the wear and tear or expiration of assets over time.
How do you interpret D&A?
Higher levels suggest significant capital investment in infrastructure or intellectual property, while lower levels may indicate aging assets or a shift toward asset-light models.
How does D&A compare across companies?
Common in capital-intensive industries like medical device manufacturing; peers often report this as a percentage of revenue.